Home/Filings/4/0001140361-07-020943
4//SEC Filing

SCICLONE PHARMACEUTICALS INC 4

Accession 0001140361-07-020943

CIK 0000880771operating

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 12:05 PM ET

Size

19.3 KB

Accession

0001140361-07-020943

Insider Transaction Report

Form 4
Period: 2007-11-01
Transactions
  • Purchase

    Common Stock

    2007-11-02$2.05/sh+29,119$59,6366,282,736 total(indirect: I)
  • Purchase

    Common Stock

    2007-11-01$2.05/sh+25,000$51,2506,253,617 total(indirect: I)
Transactions
  • Purchase

    Common Stock

    2007-11-01$2.05/sh+25,000$51,2506,253,617 total(indirect: I)
  • Purchase

    Common Stock

    2007-11-02$2.05/sh+29,119$59,6366,282,736 total(indirect: I)
Footnotes (1)
  • [F1]Shares directly owned by Defiante Farmaceutica, L.D.A. (?Defiante?). Defiante is 58% directly owned by Sigma Tau Finanzaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidi-ary, Sigma Tau International S.A.

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000880771

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 12:05 PM ET
Size
19.3 KB